North America Colorectal Cancer Screening Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The North American Colorectal Cancer Screening Market Report is Segmented by Screening Tests (Stool-Based Tests, Colonoscopy, CT Colonography (Virtual Colonoscopy), Flexible Sigmoidoscopy, and Other Tests), End Users (Hospitals, Diagnostic Centers/Laboratories, and Other End Users), and Geography (United States, Canada, and Mexico).

North America Colorectal Cancer Screening Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

North America Colorectal Cancer Screening Market Size

View Global Report
North America Colorectal Cancer Screening Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Market Size (2025) USD 7.63 Billion
Market Size (2030) USD 10.55 Billion
CAGR (2025 - 2030) 6.70 %
Market Concentration Low

Major Players

North America Colorectal Cancer Screening Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of North America Colorectal Cancer Screening Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

North America Colorectal Cancer Screening Market Analysis

The North America Colorectal Cancer Screening Market size is estimated at USD 7.63 billion in 2025, and is expected to reach USD 10.55 billion by 2030, at a CAGR of 6.7% during the forecast period (2025-2030).

  • The North American colorectal cancer screening market is experiencing growth due to several factors, such as the increasing prevalence of colorectal cancer, technological advancements, and cancer prevention initiatives. The high prevalence of colorectal cancers in the region is one of the major factors driving the market growth, as it is expected to increase the usage of colorectal cancer screening tests.
  • For instance, according to data published by the Canadian Cancer Society in May 2024, colorectal cancer is expected to be the fourth most commonly diagnosed cancer in Canada in 2024. In addition, according to the same source, 25,200 new colorectal cancer cases are estimated to be diagnosed in Canada in 2024. Similarly, according to the data published by the International Agency for Research on Cancer in February 2024, the number of new colorectum cancer cases was reported to be 16.1 thousand cases in 2022 and is estimated to reach 17.5 thousand cases in Mexico by 2025. Thus, the increasing prevalence of colorectal cancer is driving the need for screening, which is expected to contribute to market growth during the forecast period significantly. Moreover, colorectal cancer prevention initiatives are expected to boost the market growth. For instance, according to the data updated by Ohio State University in 2023, the Ohio Colorectal Cancer Prevention Initiative (OCCPI) is a statewide initiative in Ohio, United States, to screen newly diagnosed colorectal cancer (CRC) patients and their biological relatives for Lynch syndrome. This cancer-causing condition occurs when a person inherits a mutation in one of four genes. These initiatives increase the awareness of colorectal cancer screening, thereby boosting the demand, and are expected to drive market growth during the forecast period.
  • Thus, the above factors, such as the rising prevalence of colorectal cancer and cancer prevention initiatives, are expected to boost the market growth. However, high screening test costs are expected to impede market growth during the forecast period.

North America Colorectal Cancer Screening Industry Overview

The North American colorectal cancer screening market is fragmented due to the presence of many small and large market players. These market players are involved in various strategic activities such as agreements, partnerships, and developments to increase the product portfolio of the companies in the region. Some key North American colorectal cancer screening market players are Abbott Laboratories, Epigenomics Inc., Exact Sciences Corporation, F. Hoffmann-La Roche AG, Novigenix SA, Siemens Healthineers, and Sysmex Corporation.

North America Colorectal Cancer Screening Market Leaders

  1. Abbott Laboratories

  2. Epigenomics Inc.

  3. Exact Sciences Corporation

  4. Clinical Genomics Technologies Pty Ltd.

  5. Hemosure Inc.

  6. *Disclaimer: Major Players sorted in no particular order
North America Colorectal Cancer Screening Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

North America Colorectal Cancer Screening Market News

  • May 2024: Geneoscopy Inc. received approval from the US FDA for its non-invasive colorectal cancer screening test, ColoSense. It is indicated as a screening test for adults 45 years of age or older who are at typical average risk for developing colorectal cancer.
  • May 2024: Exact Sciences Corp. presented its strategies and advancements for improving colorectal cancer screening rates and outcomes in Washington, DC. The data include Cologuard, a non-invasive screening test for colorectal cancer in patients 45 and older at average risk, and the next-generation Cologuard test in development, Cologuard Plus.

North America Colorectal Cancer Screening Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Colorectal Cancer
    • 4.2.2 Technological advancements and Increasing Cancer Prevention Initiatives
  • 4.3 Market Restraints
    • 4.3.1 High Screening Tests Costs
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD)

  • 5.1 By Screening Tests
    • 5.1.1 Stool-based Tests
    • 5.1.1.1 Fecal Immunochemical Test (FIT)
    • 5.1.1.2 Guaiac-based Fecal Occult Blood Test (gFOBT)
    • 5.1.1.3 Stool DNA Test
    • 5.1.2 Colonoscopy
    • 5.1.3 CT Colonography (Virtual Colonoscopy)
    • 5.1.4 Flexible Sigmoidoscopy
    • 5.1.5 Other Screening Tests
  • 5.2 By End User
    • 5.2.1 Hospitals
    • 5.2.2 Diagnostic Centers/Laboratories
    • 5.2.3 Other End Users
  • 5.3 Geography
    • 5.3.1 United States
    • 5.3.2 Canada
    • 5.3.3 Mexico

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Clinical Genomics Technologies Pty Ltd
    • 6.1.3 Epigenomics Inc.
    • 6.1.4 Exact Sciences Corporation
    • 6.1.5 F. Hoffmann-La Roche AG
    • 6.1.6 Hemosure Inc.
    • 6.1.7 Novigenix SA
    • 6.1.8 Quidel Corporation
    • 6.1.9 Siemens Healthineers AG
    • 6.1.10 Sysmex Corporation
    • 6.1.11 EKF Diagnostics
    • 6.1.12 MAINZ BIOMED N.V.
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

North America Colorectal Cancer Screening Industry Segmentation

As per the report's scope, colorectal cancer (CRC) is also known as bowel cancer and colon cancer. It is a cancer of the colon or rectum, usually located at the digestive tract's lower end. Colorectal cancer screening tests use kits and various medical devices to diagnose cancer. The North American colorectal cancer screening market is segmented by screening tests, end users, and geography. The market is segmented by screening tests into stool-based tests, colonoscopy, CT colonography, flexible sigmoidoscopy, and other screening tests. The other screening tests include liquid biopsy, double-contrast barium enema (DCBE), and other tests. By end users, the market is segmented into hospitals, diagnostic centers/laboratories, and other end users. The other end users include gastrointestinal clinics and specialty care centers. The market is segmented by geography into the United States, Canada, and Mexico. The report offers the value (in USD) for the above segments.

By Screening Tests Stool-based Tests Fecal Immunochemical Test (FIT)
Guaiac-based Fecal Occult Blood Test (gFOBT)
Stool DNA Test
Colonoscopy
CT Colonography (Virtual Colonoscopy)
Flexible Sigmoidoscopy
Other Screening Tests
By End User Hospitals
Diagnostic Centers/Laboratories
Other End Users
Geography United States
Canada
Mexico
Need A Different Region or Segment?
Customize Now

North America Colorectal Cancer Screening Market Research FAQs

How big is the North America Colorectal Cancer Screening Market?

The North America Colorectal Cancer Screening Market size is expected to reach USD 7.63 billion in 2025 and grow at a CAGR of 6.70% to reach USD 10.55 billion by 2030.

What is the current North America Colorectal Cancer Screening Market size?

In 2025, the North America Colorectal Cancer Screening Market size is expected to reach USD 7.63 billion.

Who are the key players in North America Colorectal Cancer Screening Market?

Abbott Laboratories, Epigenomics Inc., Exact Sciences Corporation, Clinical Genomics Technologies Pty Ltd. and Hemosure Inc. are the major companies operating in the North America Colorectal Cancer Screening Market.

What years does this North America Colorectal Cancer Screening Market cover, and what was the market size in 2024?

In 2024, the North America Colorectal Cancer Screening Market size was estimated at USD 7.12 billion. The report covers the North America Colorectal Cancer Screening Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the North America Colorectal Cancer Screening Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

North America Colorectal Cancer Screening Industry Report

Statistics for the 2025 North America Colorectal Cancer Screening market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. North America Colorectal Cancer Screening analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

North America Colorectal Cancer Screening Market Report Snapshots